State of the art - Extracorporeal membrane oxygenation as a bridge to thoracic transplantation.
ECMO
bridge
heart
heart-lung
lung
thoracic transplant
Journal
Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
revised:
11
11
2022
received:
16
09
2022
accepted:
28
11
2022
pubmed:
6
12
2022
medline:
11
2
2023
entrez:
5
12
2022
Statut:
ppublish
Résumé
Extracorporeal membrane oxygenation (ECMO) has revolutionized the treatment of refractory cardiac and respiratory failure, and its use continues to increase, particularly in adults. However, ECMO-related morbidity and mortality remain high. In this review, we investigate and expand upon the current state of the art in thoracic transplant and extracorporeal life support (ELS). In particular, we examine recent increase in incidence of heart transplant in patients supported by ECMO; the potential changes in patient care and selection for transplant in the years prior to updated United Network for Organ Sharing (UNOS) organ allocation guidelines versus those in the years following, particularly where these guidelines pertain to ECMO; and the newly revived practice of heart-lung block transplants (HLT) and the prevalence and utility of ECMO support in patients listed for HLT. Our findings highlight encouraging outcomes in patients bridged to transplant with ECMO, considerable changes in treatment surrounding the updated UNOS guidelines, and complex, diverse outcomes among different centers in their care for increasingly ill patients listed for thoracic transplant.
Sections du résumé
BACKGROUND
Extracorporeal membrane oxygenation (ECMO) has revolutionized the treatment of refractory cardiac and respiratory failure, and its use continues to increase, particularly in adults. However, ECMO-related morbidity and mortality remain high.
MAIN TEXT
In this review, we investigate and expand upon the current state of the art in thoracic transplant and extracorporeal life support (ELS). In particular, we examine recent increase in incidence of heart transplant in patients supported by ECMO; the potential changes in patient care and selection for transplant in the years prior to updated United Network for Organ Sharing (UNOS) organ allocation guidelines versus those in the years following, particularly where these guidelines pertain to ECMO; and the newly revived practice of heart-lung block transplants (HLT) and the prevalence and utility of ECMO support in patients listed for HLT.
CONCLUSIONS
Our findings highlight encouraging outcomes in patients bridged to transplant with ECMO, considerable changes in treatment surrounding the updated UNOS guidelines, and complex, diverse outcomes among different centers in their care for increasingly ill patients listed for thoracic transplant.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14875Informations de copyright
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Kwak J, Majewski MB, Jellish WS. Extracorporeal membrane oxygenation: the new Jack-of-all-trades? J Cardiothorac Vasc Anesth. 2020;34:192-207.
Pasrija C, Mackowick KM, Raithel M, et al. Ambulation with femoral arterial cannulation can be safely performed on venoarterial extracorporeal membrane oxygenation. Ann Thorac Surg. 2019;107:1389-1394.
Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet. 2009;373:1874-1882.
Shudo Y, Kasinpila P, Lee AM, et al. Ambulating femoral venoarterial extracorporeal membrane oxygenation bridge to heart-lung transplant. J Thorac Cardiovasc Surg. 2018;156:e135.
Orozco-Hernandez EJ, Melnikoff B, Lusby M, Tallaj J, Hoopes CW. Peripheral femoral venoarterial extracorporeal membrane oxygenation as bridge to heart-lung transplant omne iter incipit primus. J Card Surg. 2020;35:2077-2080. doi:10.1111/jocs.14779
Colvin M, Smith JM, Hadley N, et al. OPTN/SRTR 2018 Annual Data Report: heart. Am J Transplant. 2020;20(s1):340-426. doi:10.1111/ajt.15676
Colvin M, Smith JM, Hadley N, et al. OPTN/SRTR 2017 Annual Data Report: heart. Am J Transplant. 2019;19:323-403.
Adult heart allocation-Organ Procurement and Transplantation Network. 2018. Accessed October 8, 2019. https://optn.transplant.hrsa.gov/learn/professional-education/adult-heart-allocation/
Meyer DM, Rogers JG, Edwards LB, et al. the future direction of the adult heart allocation system in the United States. Am J Transplant. 2015;15(1):44-54. doi:10.1111/ajt.13030
Extracorporeal Life Support Organization Registry Report. Accessed June 25, 2020. https://www.elso.org/Registry/Statistics/InternationalSummary.aspx
Jasseron C, Lebreton G, Cantrelle C, et al. Impact of heart transplantation on survival in patients on venoarterial extracorporeal membrane oxygenation at listing in France. Transplantation. 2016;100(9):1979-1987. doi:10.1097/TP.0000000000001265
Fukuhara S, Takeda K, Kurlansky PA, Naka Y, Takayama H. Extracorporeal membrane oxygenation as a direct bridge to heart transplantation in adults. J Thorac Cardiovasc Surg. 2018;155(4):1607-1618.e6. doi:10.1016/j.jtcvs.2017.10.152
OPTN Policies Effective as of June 18 2020. Accessed June 26, 2020. https://optn.transplant.hrsa.gov/media/1200/optn_policies.pdf
Poptsov V, Spirina E, Dogonasheva A, Zolotova E. Five years’ experience with a peripheral veno-arterial ECMO for mechanical bridge to heart transplantation. J Thorac Dis. 2019;11(6):S889-S901. doi:10.21037/jtd.2019.02.55
Hong KN, Iribarne A, Worku B, et al. Who is the high-risk recipient? Predicting mortality after heart transplant using pretransplant donor and recipient risk factors. Ann Thorac Surg. 2011;92(2):520-527. doi:10.1016/j.athoracsur.2011.02.086
Russo MJ, Iribarne A, Hong KN, et al. Factors associated with primary graft failure after heart transplantation. Transplantation. 2010;90(4):444-450. doi:10.1097/TP.0b013e3181e6f1eb
Kilic A, Hickey G, Mathier MA, et al. Outcomes of the first 1300 adult heart transplants in the United States after the allocation policy change. Circulation. 2020;141(20):1662-1664. doi:10.1161/CIRCULATIONAHA.119.045354
Yeen W, Polgar A, Guglin M, et al. Outcomes of adult orthotopic heart transplantation with extended allograft ischemic time. Transplant Proc. 2013;45(6):2399-2405. doi:10.1016/j.transproceed.2013.04.003
Nicoara A, Ruffin D, Cooter M, et al. Primary graft dysfunction after heart transplantation: incidence, trends, and associated risk factors. Am J Transplant. 2018;18(6):1461-1470. doi:10.1111/ajt.14588
John MM, Shih W, Estevez D, et al. Interaction between ischemic time and donor age on adult heart transplant outcomes in the modern era. Ann Thorac Surg. 2019;108(3):744-748. doi:10.1016/j.athoracsur.2019.03.042
Guglin M, Zucker MJ, Bazan VM, et al. Venoarterial ECMO for adults: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019;73:698-716.
Barge-Caballero E, Almenar-Bonet L, Gonzalez-Vilchez F, et al. Clinical outcomes of temporary mechanical circulatory support as a direct bridge to heart transplantation: a nationwide Spanish registry. Eur J Heart Fail. 2018;20:178-186.
Zalawadiya S, Fudim M, Bhat G, Cotts W, Lindenfeld J. Extracorporeal membrane oxygenation support and post-heart transplant outcomes among United States adults. J Heart Lung Transplant. 2017;36:77-81.
Shah AS, Stevenson LW. The 4 dimensions of heart allocation in an increasingly complex universe. J Am Coll Cardiol. 2020;75:2917-2920.
Coutance G, Jacob N, Demondion P, et al. Favorable outcomes of a direct heart transplantation strategy in selected patients on extracorporeal membrane oxygenation support. Crit Care Med. 2020; 48: 498-506.
Loyaga-Rendon RY, Boeve T, Tallaj J, et al. Extracorporeal membrane oxygenation as a bridge to durable mechanical circulatory support: an analysis of the STS-INTERMACS database. Circ Heart Fail. 2020;13:e006387.
Hess NR, Hickey GW, Sultan I, Kilic A. Extracorporeal membrane oxygenation bridge to heart transplant: trends following the allocation change. J Card Surg. 2021;36:40-47. doi:10.1111/jocs.15118
Yin MY, Wever-Pinzon O, Mehra MR, et al. Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices. J Heart Lung Transplant. 2019;38:858-869.
Elde S, He H, Lingala B, et al. Analysis of the revised heart allocation policy and the impact of increased mechanical circulatory support on survival. J Thorac Cardiovasc Surg. 2022. doi:10.1016/j.jtcvs.2021.11.076
Mastoris I, onna JE, Hu J, et al. Use of extracorporeal membrane oxygenation as bridge to replacement therapies in cardiogenic shock: insights from the Extracorporeal Life Support Organization. Circ Heart Fail. 2022;15:e008777. doi:10.1161/CIRCHEARTFAILURE.121.008777
MacLaren G, Combes A, Bartlett RH. Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era. Intensive Care Med. 2012;38:210-220.
Tay CK, Sung K, Cho YH. Clinical pearls in venovenous extracorporeal life support for adult respiratory failure. ASAIO J. 2018;64:1-9.
United Network for Organ Sharing. Transplant trends. Accessed April 1, 2018. https://unos.org/data/transplant-trends/
Moreno Garijo J, Cypel M, McRae K, Machuca T, Cunningham V, Slinger P. The evolving role of extracorporeal membrane oxygenation in lung transplantation: implications for anesthetic management. J Cardiothorac Vasc Anesth. 2019;33:1995-2006.
Egan TM, Edwards LB. Effect of the lung allocation score on lung transplantation in the United States. J Heart Lung Transplant. 2016;35:433-439.
Hakim AH, Ahmad U, McCurry KR, et al. Contemporary outcomes of extracorporeal membrane oxygenation used as bridge to lung transplantation. Ann Thorac Surg. 2018;106:192-198.
Chambers DC, Yusen RD, Cherikh WS, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung and HeartLung Transplantation Report-2017; focus theme: allograft ischemic time. J Heart Lung Transplant. 2017;36:1047-1059.
Extracorporeal Life Support Organization. ECLS Registry report. Accessed November 7, 2022. http://www.elso.org/
Hayanga JW, Lira A, Aboagye JK, et al. Extracorporeal membrane oxygenation as a bridge to lung transplantation: what lessons might we learn from volume and expertise? Interact Cardiovasc Thorac Surg. 2016;22:406-410.
Ali NA, O'Brien Jr JM, Hoffmann SP, et al. Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med. 2008;178:261-268.
Hoopes CW, Kukreja J, Golden J, Davenport DL, Diaz-Guzman E, Zwischenberger JB. Extracorporeal membrane oxygenation as a bridge to pulmonary transplantation. J Thorac Cardiovasc Surg. 2013;145:862-868.
Rehder KJ, Turner DA, Hartwig MG, et al. Active rehabilitation during extracorporeal membrane oxygenation as a bridge to lung transplantation. Respir Care. 2013;58:1291-1298.
Bain JC, Turner DA, Rehder KJ, et al. Economic outcomes of extracorporeal membrane oxygenation with and without ambulation as a bridge to lung transplantation. Respir Care. 2016;61:1-7.
Biscotti M, Bacchetta M. The “sport model”: extracorporeal membrane oxygenation using the subclavian artery. Ann Thorac Surg. 2014;98:1487-1489.
Hoopes CW. Ambulatory extracorporeal membrane oxygenation. Oper Tech Thorac Cardiovasc Surg. 2014;19(2):129-137. doi:10.1053/j.optechstcvs.2014.09.002
Rajagopal K, Hoeper MM. State of the art: bridging to lung transplantation using artificial organ support technologies. J Heart Lung Transplant. 2016;35:1385-1398.
Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374:1351-1363. doi:10.1016/S0140-6736(09)61069-2
Noah MA, Peek GJ, Finney SJ, et al. Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A (H1N1). JAMA. 2011;306:1659-1668.
Combes A, Pellegrino V. Extracorporeal Membrane Oxygenation for 2009 Influenza A (H1N1)-associated acute respiratory distress syndrome. Semin Respir Crit Care Med. 2011;32:188-194.
Brodie D, Bacchetta M. Extracorporeal membrane oxygenation for ARDS in adults. N Engl J Med. 2011;365:1905-1914.
Biscotti M, Sonett J, Bacchetta M. ECMO as bridge to lung transplant. Thorac Surg Clin. 2015;25:17-25. doi:10.1016/j.thorsurg.2014.09.010
Sharma NS, Hartwig MG, Hayes Jr D. Extracorporeal membrane oxygenation in the pre and post lung transplant period. Ann Transl Med. 2017;5(4):74. doi:10.21037/atm.2017.02.09
Makdisi G, Wang I-W. Extra Corporeal Membrane Oxygenation (ECMO) review of a lifesaving technology. J Thorac Dis. 2015;7:E166-E176.
Leard L, Holm AM, Valapour M, et al. Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2021; 40(11):1349-1379.
Keshavamurthy S, Bazan V, Tribble TA, et al. Ambulatory extracorporeal membrane oxygenation (ECMO) as a bridge to lung transplantation. Indian J Thorac Cardiovasc Surg. 2021;37(3):S366-S379. doi:10.1007/s12055-021-01210-4
George TJ, Beaty CA, Kilic A, et al. Outcomes and temporal trends among high-risk patients after lung transplantation in the United States. J Heart Lung Transplant. 2012;31:1182-1191.
Hayes Jr D, Tobias JD, Tumin D. Center volume and extracorporeal membrane oxygenation support at lung transplantation in the lung allocation score era. Am J Respir Crit Care Med. 2016;194:317-326.
Shafii AE, Mason DP, Brown CR, et al. Growing experience with extracorporeal membrane oxygenation as a bridge to lung transplantation. ASAIO J. 2012;58:526-529.
Javidfar J, Brodie D, Iribarne A, et al. Extracorporeal membrane oxygenation as a bridge to lung transplantation and recovery. J Thorac Cardiovasc Surg. 2012;144:716-721.
Salam S, Kotloff R, Garcha P, et al. Lung transplanation after 125 days on ECMO for severe refractory hypoxemiawith no prior lung disease. ASAIO J. 2017;63(5):e66-e68. https://doi.org/10.1097/MAT.0000000000000450
Kon ZN, Wehman PB, Gibber M, et al. Venovenous extracorporeal membrane oxygenation as a bridge to lung transplantation: successful transplantation after 155 days of support. Ann Thorac Surg. 2015;99:704-707.
Turner DA, Cheifetz IM, Rehder KJ, et al. Active rehabilitation and physical therapy during extracorporeal membrane oxygenation while awaiting lung transplantation: a practical approach. Crit Care Med. 2011;39:2593-2598.
Orozco-Hernández EJ, Gongora E, Bellot C, et al. Extracorporeal Membrane Oxygenation as a bridge: no middle ground. Folium olivae o spinam coronam. Case Series. Cir Card Mex. 2020;5(4):137-143.
Tiruvoipati R, Buscher H, Winearls J, et al. Early experience of a new extracorporeal carbon dioxide removal device for acute hypercapnic respiratory failure. Crit Care Resusc. 2016;18:261-269.
Kon ZN, Pasrija C, Shah A, et al. Venovenous extracorporeal membrane oxygenation with atrial septostomy as a bridge to lung transplantation. Ann Thorac Surg. 2016;101:1166-1169.
Chicotka S, Rosenzweig EB, Brodie D, et al. The “Central Sport Model”: extracorporeal membrane oxygenation using the innominate artery for smaller patients as bridge to lung transplantation. ASAIO J. 2017;63(4):e39-e44. https://doi.org/10.1097/MAT.0000000000000427
Saeed D, Stosik H, Islamovic M, et al. Femoro-femoral versus atrio-aortic extracorporeal membrane oxygenation: selecting the ideal cannulation technique. Artif Organs. 2014;38:549-555.
Saeed D, Maxhera B, Westenfeld R, et al. An alternative approach for perioperative extracorporeal life support implantation. Artif Organs. 2015;39:719-723.
Orozco-Hernandez EJ, Munoz-Largacha J, Lusby M, Hoopes CW. Ambulatory femoral venovenous extracorporeal membrane oxygenation with a dual-lumen cannula. JTCVS Tech. 2021;9:199-201. doi:10.1016/j.xjtc.2021.06.013
Mazzeffi M, Kon Z, Menaker J, et al. Large dual-lumen extracorporeal membrane oxygenation cannulas are associated with more intracranial hemorrhage. ASAIO J. 2019;65:674-677. doi:10.1097/MAT.0000000000000917
Kukreja J, Tsou S, Chen J, et al. Risk factors and outcomes of extracorporeal membrane oxygenation as a bridge to lung transplantation. Semin Thorac Cardiovasc Surg. 2020;32:772-785.
Lang G, Taghavi S, Aigner C, et al. Primary lung transplantation after bridge with extracorporeal membrane oxygenation: a plea for a shift in our paradigms for indications. Transplantation. 2012;93:729-736.
Toyoda Y, Bhama JK, Shigemura N, et al. Efficacy of extracorporeal membrane oxygenation as a bridge to lung transplantation. J Thorac Cardiovasc Surg. 2013;145:1065-1071.
Bain JC, Turner DA, Rehder KJ, et al. Economic outcomes of extracorporeal membrane oxygenation with and without ambulation as a bridge to lung transplantation. Respir Care. 2016;61:1-7. doi:10.4187/respcare.03729
Tipograf Y, Salna M, Minko E, et al. Outcomes of extracorporeal membrane oxygenation as a bridge to lung transplantation. Ann Thorac Surg. 2019;107:1456-1463.
Iyengar A, Eisenring C, DePasquale E, Ross D, Ardehali A. ECMO as a bridge to lung transplantation: an analysis of the UNOS database. J Heart Lung Transplant. 2016;35:S303-S304.
Banga A, Batchelor E, Mohanka M, et al. Predictors of outcome among patients on extracorporeal membrane oxygenation as a bridge to lung transplantation. Clin Transplant. 2017;31:e12990.
Chicotka S, Pedroso FE, Agerstrand CL, et al. Increasing opportunity for lung transplant in interstitial lung disease with pulmonary hypertension. Ann Thorac Surg. 2018;106:1812-1819.
Langer F, Aliyev P, Schafers HJ, et al. Improving outcomes in bridge-to-transplant: extended extracorporeal membrane oxygenation support to obtain optimal donor lungs for marginal recipients. ASAIO J. 2018;106:1812-1819.
Schechter MA, Ganapathi AM, Englum BR, et al. Spontaneously breathing extracorporeal membrane oxygenation support provides the optimal bridge to lung transplantation. Transplantation. 2016;100:2699-2704.
Habertheuer A, Richards T, Sertic F, et al. Stratification risk analysis in bridging patients to lung transplant on ECMO: the STABLE risk score. Ann Thorac Surg. 2020;110:1175-1184.
Chambers DC, Cherikh WS, Cherikh WS, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult lung and heart-lung transplantation report 2019; focus theme: donor and recipient size match. J Heart Lung Transplant. 2019;38(10):1056-1066.
Chambers DC, Cherikh WS, Goldfarb S, et al. The registry of the International Society for Heart and Lung Transplantation: Thirty-Fifth Adult Heart Transplantation Report 2018; focus theme: multiorgan transplantation. J Heart Lung Transplant. 2018;37(10):1155-1168.
Reitz BA. Heart-lung transplantation. Chest. 1988;93:450-451.
Rose J, Zimmerman H, Coelho-Anderson R, Copeland JG. Twenty-five-year survival after heart-lung transplantation: a milestone. J Heart Lung Transplant. 2011;30:385-388.
Aladdein M, Chatterjee S, Loor G. Bridging to lung transplantation. Crit Care Clin. 2019;35:11-25.
Hayanga JW, Aboagye JK, Hayanga HK, Luketich JD, D'Cunha J. Extracorporeal membrane oxygenation as a bridge to lung re-transplantation: is there a role? J Heart Lung Transplant. 2016;35:901-905.
Sertic F, Crespo MM, Habertheuer A, et al. Early outcomes with the use of extra corporeal membrane oxygenation as a bridge to combined heart and lung transplant. J Heart Lung Transplant. 2019;38(4):S55.
Shudo Y, Wang H, Lingala B, et al. Evaluation of risk factors for heart-lung transplant recipient outcome: an analysis of the united network for organ sharing database. Circulation. 2019;140:1261-1272.
Shudo Y, Elde S, Lingala B, et al. Extracorporeal membrane oxygenation bridge to heart-lung transplantation. ASAIO J. 2021;68(3):44-47. doi:10.1097/MAT.0000000000001457